|
Index of reports
> Cases with White Blood Cell Count Increased (105)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clozapine where reactions include white blood cell count increased. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 105 Next >>
Possible Clozapine side effects in 36 year old female
Reported by a physician from United Kingdom on 2012-08-27
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Pyrexia, Mean Cell Volume Decreased, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Neutrophil Count Increased, Hiatus Hernia, Cardiac Murmur, Urinary Tract Infection, Physical Assault, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Clozapine
Administration route: Oral
Start date: 2008-06-05
Clozapine
Administration route: Oral
Start date: 2008-05-19
Clozapine
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Diazepam
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Indication: Product Used FOR Unknown Indication
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Indication: Product Used FOR Unknown Indication
Lansoprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Furosemide; Ramipril; Atorvastatin; Bendroflumethiazide; Aripiprazole
Possible Clozapine side effects in female
Reported by a consumer/non-health professional from Germany on 2012-08-22
Patient: female
Reactions: Neutrophil Count Increased, Antipsychotic Drug Level Increased, Fear of Death, Tachycardia, Condition Aggravated, Cerebrovascular Accident, Viith Nerve Paralysis, Dysarthria, Antipsychotic Drug Level Below Therapeutic, Incontinence, Psychotic Disorder, Salivary Hypersecretion, White Blood Cell Count Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Clozapine
Dosage: 100 mg, qid
Administration route: Oral
Start date: 2011-02-01
End date: 2011-08-01
Clozapine
Dosage: 300 mg, (0-0-50-250-mg qd)
Administration route: Oral
Start date: 2011-08-04
Other drugs received by patient: Lorazepam; Valproate Sodium
Possible Clozapine side effects in female
Reported by a physician from United Kingdom on 2012-08-21
Patient: female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Mean Cell Volume Decreased, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Cardiac Murmur, Neutrophil Count Increased, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, Aggression, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: unk ukn, qd
Clozapine
Dosage: unk ukn, unk
Start date: 2008-05-19
Clozaril
Administration route: Oral
Start date: 2008-06-05
Clozaril
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Dosage: 250 mg, qd
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2008-05-19
Diazepam
Dosage: unk ukn, prn
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Administration route: Oral
Folic Acid
Dosage: 5 mg, qd
Administration route: Oral
Lactulose
Dosage: 10 ml, prn
Lansoprazole
Dosage: 30 mg, qd
Administration route: Oral
Perindopril Erbumine
Dosage: 2 mg, qd
Administration route: Oral
Trimethoprim
Dosage: unk ukn, unk
Indication: Urinary Tract Infection
Zopiclone
Dosage: 3.75 mg, qhs
Other drugs received by patient: Furosemide; Atorvastatin; Abilify; Ramipril; Bendrofluazide
Possible Clozapine side effects in male
Reported by a consumer/non-health professional from Argentina on 2012-08-20
Patient: male
Reactions: Mumps, White Blood Cell Count Increased
Drug(s) suspected as cause:
Clozapine
Other drugs received by patient: Olanzapine; Benzodiazepines
Possible Clozapine side effects in female
Reported by a consumer/non-health professional from Germany on 2012-08-17
Patient: female
Reactions: Neutrophil Count Increased, Fear of Death, Tachycardia, Cerebrovascular Accident, Viith Nerve Paralysis, Dysarthria, Psychotic Disorder, Incontinence, Salivary Hypersecretion, White Blood Cell Count Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Clozapine
Dosage: 100 mg, qid
Administration route: Oral
Start date: 2011-02-01
End date: 2011-08-01
Clozapine
Dosage: 300 mg, (0-0-50-250-mg qd)
Administration route: Oral
Start date: 2011-08-04
Other drugs received by patient: Valproate Sodium
Possible Clozapine side effects in 36 year old female
Reported by a physician from United Kingdom on 2012-08-16
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Pyrexia, Mean Cell Volume Decreased, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Cardiac Murmur, Neutrophil Count Increased, Urinary Tract Infection, Physical Assault, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozapine
Administration route: Oral
Start date: 2008-05-19
Clozapine
Administration route: Oral
Start date: 2008-06-05
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Diazepam
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Indication: Product Used FOR Unknown Indication
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Indication: Product Used FOR Unknown Indication
Lansoprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Atorvastatin; Bendroflumethiazide; Furosemide; Aripiprazole; Ramipril
Possible Clozapine side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-09
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Mean Cell Volume Decreased, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Neutrophil Count Increased, Cardiac Murmur, Hiatus Hernia, Urinary Tract Infection, Physical Assault, Skin Disorder, Monocyte Count Increased, Aggression, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2005-05-01
End date: 2005-05-19
Clozapine
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2008-05-19
Clozapine
Dosage: unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2008-06-05
Clozapine
Dosage: unk
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2005-05-01
End date: 2005-05-19
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Indication: Schizophrenia
Start date: 2006-06-05
End date: 2006-07-13
Diazepam
Dosage: unk
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Indication: Product Used FOR Unknown Indication
Folic Acid
Dosage: 5 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Dosage: 10 ml, prn
Indication: Product Used FOR Unknown Indication
Lansoprazole
Dosage: 30 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Dosage: 2 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Dosage: unk
Indication: Urinary Tract Infection
Zopiclone (Unknown)
Dosage: 3.75 mg, daily, nocte
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Furosemide; Ramipril; Aripiprazole; Atorvastatin; Bendrofluazide; Abilify; Zopiclone
Possible Clozapine side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-08
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Cardiac Murmur, Neutrophil Count Increased, Diabetes Mellitus, Physical Assault, Skin Disorder, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Staphylococcal Infection, Thrombocytosis, Blood Culture Positive, Sinus Tachycardia, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: po
Administration route: Oral
Start date: 2008-05-19
Clozaril
Dosage: 250 mg;qd;po
Administration route: Oral
Indication: Schizophrenia
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Dosage: 250 mg;qd;po
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Diazepam
Enulose
Dosage: 10 ml
Ferrous Sulfate TAB
Dosage: 200 mg;bid;po
Administration route: Oral
Folic Acid
Dosage: 5 mg;qd;po
Administration route: Oral
Lansoprazole
Dosage: 30 mg;qd;po
Administration route: Oral
Perindopril Erbumine
Dosage: 2 mg;qd;po
Administration route: Oral
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone (Zopiclone)
Dosage: 3.75 mg
Other drugs received by patient: Atorvastatin; Bendroflumethiazide; Ramipril; Zopiclone; Abilify; Furosemide; Aripiprazole
Possible Clozapine side effects in 46 year old female
Reported by a consumer/non-health professional from United Kingdom on 2012-08-03
Patient: 46 year old female
Reactions: Neutrophil Count Increased, Blood Creatine Phosphokinase Increased, Pneumonia, Blood Urea Decreased, Multiple Drug Overdose, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 40 dosage forms, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-04-28
End date: 2012-06-28
Simvastatin
Dosage: oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Clozapine side effects in male
Reported by a physician from Argentina on 2012-08-02
Patient: male
Reactions: Mumps, White Blood Cell Count Increased
Drug(s) suspected as cause:
Clozapine
Other drugs received by patient: Benzodiazepines; Olanzapine
Possible Clozapine side effects in 36 year old female
Reported by a physician from United Kingdom on 2012-08-02
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Mean Cell Volume Decreased, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Neutrophil Count Increased, Hiatus Hernia, Cardiac Murmur, Urinary Tract Infection, Physical Assault, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozapine
Administration route: Oral
Start date: 2008-06-05
Clozapine
Administration route: Oral
Start date: 2008-05-19
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Diazepam
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Indication: Product Used FOR Unknown Indication
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Indication: Product Used FOR Unknown Indication
Lansoprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Aripiprazole; Ramipril; Bendroflumethiazide; Atorvastatin; Furosemide
Possible Clozapine side effects in
Reported by a consumer/non-health professional from Argentina on 2012-07-31
Patient:
Reactions: Pharyngotonsillitis, White Blood Cell Count Increased
Drug(s) suspected as cause:
Clozapine
Possible Clozapine side effects in 45 year old male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-31
Patient: 45 year old male
Reactions: Blood Creatine Phosphokinase Increased, Antipsychotic Drug Level Increased, Blood Urea Increased, Glomerular Filtration Rate Decreased, Autonomic Nervous System Imbalance, Somnolence, Myoclonus, Dehydration, Neuroleptic Malignant Syndrome, Altered State of Consciousness, Blood Creatinine Increased, Blood Pressure Fluctuation, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 600 mg, unk
Clozapine
Dosage: 750 mg, unk
Possible Clozapine side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-27
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Mean Cell Volume Decreased, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Cardiac Murmur, Neutrophil Count Increased, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, Aggression, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2008-06-05
Clozapine
Dosage: unk
Administration route: Oral
Start date: 2008-05-19
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Indication: Schizophrenia
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2005-05-01
End date: 2005-05-19
Diazepam
Dosage: unk
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Indication: Product Used FOR Unknown Indication
Folic Acid
Dosage: 5 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Dosage: 10 ml, prn
Indication: Product Used FOR Unknown Indication
Lansoprazole
Dosage: 30 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Dosage: 2 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Dosage: unk
Indication: Urinary Tract Infection
Zopiclone (Unknown)
Dosage: 3.75 mg, daily, nocte
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Atorvastatin; Ramipril; Zopiclone; Abilify; Bendrofluazide; Aripiprazole; Furosemide
Possible Clozapine side effects in 36 year old female
Reported by a physician from United Kingdom on 2012-07-26
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Pyrexia, Mean Cell Volume Decreased, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Cardiac Murmur, Neutrophil Count Increased, Urinary Tract Infection, Physical Assault, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Clozapine
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozapine
Administration route: Oral
Start date: 2008-05-19
Clozapine
Administration route: Oral
Start date: 2008-06-05
Diazepam
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Indication: Product Used FOR Unknown Indication
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Indication: Product Used FOR Unknown Indication
Lansoprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Furosemide; Aripiprazole; Atorvastatin; Ramipril; Bendroflumethiazide
Possible Clozapine side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-20
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Cardiac Murmur, Urinary Tract Infection, Physical Assault, Skin Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-05
Clozapine
Start date: 2005-05-19
Clozaril
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-01-01
End date: 2005-05-19
Clozaril
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Diazepam
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Indication: Product Used FOR Unknown Indication
Lansoprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Aripiprazole; Atorvastatin; Bendrofluazide; Furosemide; Ramipril; Abilify
Possible Clozapine side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-18
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Pyrexia, Mean Cell Volume Decreased, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Cardiac Murmur, Neutrophil Count Increased, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: unk
Administration route: Oral
Start date: 2008-05-19
Clozapine
Dosage: unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2008-06-05
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Indication: Schizophrenia
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2005-05-01
End date: 2005-05-19
Diazepam
Dosage: unk
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Indication: Product Used FOR Unknown Indication
Folic Acid
Dosage: 5 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Dosage: 10 ml, prn
Indication: Product Used FOR Unknown Indication
Lansoprazole
Dosage: 30 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Dosage: 2 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Dosage: unk
Indication: Urinary Tract Infection
Zopiclone (Unknown)
Dosage: 3.75 mg, daily, nocte
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Bendrofluazide; Furosemide; Aripiprazole; Ramipril; Abilify; Zopiclone; Atorvastatin
Possible Clozapine side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-16
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Haemorrhage, Diabetes Mellitus, Tachycardia, Pyrexia, Mean Cell Volume Decreased, Constipation, Treatment Noncompliance, Abdominal Tenderness, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Cardiac Murmur, Urinary Tract Infection, Laboratory Test Interference, Physical Assault, Skin Disorder, Neutrophilia, Thrombocytosis, Sinus Tachycardia, Staphylococcus Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: po
Administration route: Oral
Start date: 2008-05-19
Clozaril
Dosage: 250 mg;qd;po
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Clozaril
Dosage: 250 mg;qd;po
Administration route: Oral
Indication: Schizophrenia
Start date: 2006-06-05
End date: 2006-07-13
Diazepam
Dosage: 10 ml
Ferrous Sulfate TAB
Dosage: 200 mg;bid;po
Administration route: Oral
Folic Acid
Dosage: 5 mg;qd;po
Administration route: Oral
Lansoprazole
Dosage: 30 mg;qd;po
Administration route: Oral
Perindopril Erbumine
Dosage: 2 mg;qd;po
Administration route: Oral
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone (Zopiclone)
Dosage: 3.75 mg
Other drugs received by patient: Ramipril; Bendroflumethiazide; Abilify; Atorvastatin; Zopiclone; Furosemide; Aripiprazole
Possible Clozapine side effects in female
Reported by a physician from United Kingdom on 2012-07-16
Patient: female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Pyrexia, Mean Cell Volume Decreased, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Cardiac Murmur, Hiatus Hernia, Neutrophil Count Increased, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, Aggression, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: unk ukn, qd
Clozapine
Dosage: unk ukn, unk
Start date: 2008-05-19
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2008-05-19
Clozaril
Dosage: unk ukn, unk
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Administration route: Oral
Start date: 2008-06-05
Clozaril
Dosage: 250 mg, qd
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Diazepam
Dosage: unk ukn, prn
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Administration route: Oral
Folic Acid
Dosage: 5 mg, qd
Administration route: Oral
Lactulose
Dosage: 10 ml, prn
Lansoprazole
Dosage: 30 mg, qd
Administration route: Oral
Perindopril Erbumine
Dosage: 2 mg, qd
Administration route: Oral
Trimethoprim
Dosage: unk ukn, unk
Indication: Urinary Tract Infection
Zopiclone
Dosage: 3.75 mg, qhs
Other drugs received by patient: Atorvastatin; Bendrofluazide; Frusemide; Ramipril; Abilify
Possible Clozapine side effects in 36 year old female
Reported by a physician from United Kingdom on 2012-07-13
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Mean Cell Volume Decreased, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Cardiac Murmur, Neutrophil Count Increased, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Clozapine
Administration route: Oral
Start date: 2008-05-19
Clozapine
Administration route: Oral
Start date: 2008-06-05
Clozapine
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Diazepam
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Indication: Product Used FOR Unknown Indication
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Indication: Product Used FOR Unknown Indication
Lansoprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Bendroflumethiazide; Ramipril; Aripiprazole; Atorvastatin; Furosemide
Possible Clozapine side effects in female
Reported by a physician from United Kingdom on 2012-07-12
Patient: female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Mean Cell Volume Decreased, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Neutrophil Count Increased, Hiatus Hernia, Cardiac Murmur, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, Aggression, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: unk ukn, qd
Start date: 2008-06-05
Clozapine
Dosage: unk ukn, unk
Start date: 2008-05-19
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Start date: 2008-05-19
Clozaril
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Administration route: Oral
Start date: 2008-06-05
Clozaril
Dosage: 250 mg, qd
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Diazepam
Dosage: unk ukn, prn
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Administration route: Oral
Folic Acid
Dosage: 5 mg, qd
Administration route: Oral
Lactulose
Dosage: 10 ml, prn
Lansoprazole
Dosage: 30 mg, qd
Administration route: Oral
Perindopril Erbumine
Dosage: 2 mg, qd
Administration route: Oral
Trimethoprim
Dosage: unk ukn, unk
Indication: Urinary Tract Infection
Zopiclone
Dosage: 3.75 mg, qhs
Other drugs received by patient: Frusemide; Ramipril; Bendrofluazide; Atorvastatin; Abilify
Possible Clozapine side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-06
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Pyrexia, Mean Cell Volume Decreased, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Neutrophil Count Increased, Cardiac Murmur, Hiatus Hernia, Physical Assault, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: unk
Administration route: Oral
Start date: 2008-06-05
Clozapine
Dosage: 250 mg, daily
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Clozapine
Dosage: 250 mg, unknown
Administration route: Oral
Start date: 2008-05-19
Clozapine
Dosage: unk
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Dosage: unk
Administration route: Oral
Start date: 2008-06-05
Clozaril
Dosage: 250 mg, daily
Administration route: Oral
Indication: Schizophrenia
Start date: 2006-06-05
End date: 2006-07-13
Clozaril
Dosage: 250 mg daily qd
Administration route: Oral
Start date: 2005-05-01
End date: 2005-05-19
Clozaril
Dosage: 250 mg, unknown
Administration route: Oral
Start date: 2008-05-19
Diazepam
Dosage: prn
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Folic Acid
Dosage: 5mg qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Dosage: 10 ml, prn
Indication: Product Used FOR Unknown Indication
Lansoprazole
Dosage: 30 mg every day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Dosage: 2mg qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone (Unknown)
Dosage: 3.75mg nocte
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Bendrofluazide; Ramipril; Atorvastatin; Aripiprazole; Frusemide
Possible Clozapine side effects in male
Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02
Patient: male, weighing 3.5 kg (7.7 pounds)
Reactions: Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Maternal Drugs Affecting Foetus, Jaundice Neonatal, Muscle Tightness, Gamma-Glutamyltransferase Increased, Blood Uric Acid Increased, Oedema, Staring, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Dysphagia, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Vomiting Neonatal, Cyanosis Neonatal, Protein Total Decreased, Muscle Twitching, Haematocrit Increased, Convulsion Neonatal, Convulsion, Haemoglobin Decreased, Poor Sucking Reflex, Aspartate Aminotransferase Increased, Swelling
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 50 mg;tid;trlp
Haloperidol Lactate
Dosage: 4 mg;tid;trpl
Indication: Foetal Exposure During Pregnancy
Possible Clozapine side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-27
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Pyrexia, Mean Cell Volume Decreased, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Hiatus Hernia, Neutrophil Count Increased, Cardiac Murmur, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Sinus Tachycardia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: unk
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozapine
Dosage: unk
Administration route: Oral
Start date: 2005-05-01
End date: 2005-05-19
Clozapine
Dosage: unk
Administration route: Oral
Start date: 2008-06-05
Clozapine
Dosage: unk
Administration route: Oral
Indication: Schizophrenia
Start date: 2008-05-19
Diazepam
Dosage: unk
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Dosage: 200 mg, bid
Indication: Product Used FOR Unknown Indication
Folic Acid
Dosage: 5 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Dosage: 10 ml, unknown
Indication: Product Used FOR Unknown Indication
Lansoprazole
Dosage: 30 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Dosage: 2 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Dosage: unk
Indication: Urinary Tract Infection
Other drugs received by patient: Zopiclone; Ramipril; Atorvastatin; Aripiprazole; Abilify; Bendrofluazide; Furosemide
Possible Clozapine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-22
Patient: male
Reactions: Confusional State, Agitation, Aphasia, Pyrexia, Disorientation, Pallor, Fall, Electroencephalogram Abnormal, Speech Disorder, Malaise, C-Reactive Protein Increased, Crepitations, Heart Rate Irregular, White Blood Cell Count Increased, Prurigo, General Physical Health Deterioration, Abnormal Behaviour, Atrial Fibrillation, Rash, Computerised Tomogram Abnormal, Diastolic Hypotension, Insomnia, Mitral Valve Incompetence, Fibrin Increased, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Other drugs received by patient: Aspirin; Tercian; Exelon; Diclofenac Sodium
Possible Clozapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-06-22
Patient: female, weighing 100.0 kg (220.0 pounds)
Reactions: White Blood Cell Count Decreased, Neutrophil Count Increased, Neoplasm Malignant, Ear Infection, Neutropenia, Neutrophil Count Decreased, Lymphoma, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 200 mg, unk
Start date: 1997-10-03
Clozaril
Dosage: 200 mg, unk
Administration route: Oral
Start date: 1997-10-03
Clozaril
Dosage: 250 mg, unk
Start date: 2012-05-08
Clozaril
Dosage: 200 mg, unk
Other drugs received by patient: Chlorhexidine Gluconate; Fludrocortisone Acetate; Ranitidine; Potassium Chloride; Valproate Sodium; Senna-Mint WAF; Magnesium Aspartate; Pravastatin; Nystatin; Gliclazide; Sulfamethoxazole and Trimethoprim; Valaciclovir; Docusate
Possible Clozapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-06-22
Patient: female, weighing 100.0 kg (220.0 pounds)
Reactions: White Blood Cell Count Decreased, Neutrophil Count Increased, Neoplasm Malignant, Ear Infection, Neutropenia, Neutrophil Count Decreased, Lymphoma, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 200 mg, unk
Start date: 1997-10-03
Clozaril
Dosage: 200 mg, unk
Administration route: Oral
Start date: 1997-10-03
Clozaril
Dosage: 200 mg, unk
Clozaril
Dosage: 250 mg, unk
Start date: 2012-05-08
Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Ranitidine; Valaciclovir; Fludrocortisone Acetate; Senna-Mint WAF; Docusate; Pravastatin; Chlorhexidine Gluconate; Gliclazide; Potassium Chloride; Nystatin; Valproate Sodium; Magnesium Aspartate
Possible Clozapine side effects in 36 year old female
Reported by a physician from United Kingdom on 2012-06-12
Patient: 36 year old female
Reactions: Body Mass Index Decreased, Diabetes Mellitus, Mean Cell Volume Decreased, Pyrexia, Constipation, Abdominal Tenderness, Malaise, Iron Deficiency Anaemia, White Blood Cell Count Increased, Neutrophil Count Increased, Cardiac Murmur, Hiatus Hernia, Urinary Tract Infection, Skin Disorder, Monocyte Count Increased, White Blood Cell Disorder, Staphylococcal Infection, Thrombocytosis, Hypertension, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Administration route: Oral
Start date: 2008-06-05
Clozapine
Administration route: Oral
Start date: 2006-06-05
End date: 2006-07-13
Clozapine
Administration route: Oral
Start date: 2008-05-19
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2005-05-01
End date: 2005-05-19
Diazepam
Indication: Product Used FOR Unknown Indication
Ferrous Sulfate TAB
Indication: Product Used FOR Unknown Indication
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lactulose
Indication: Product Used FOR Unknown Indication
Lansoprazole
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Perindopril Erbumine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trimethoprim
Indication: Urinary Tract Infection
Zopiclone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Ramipril; Atorvastatin Calcium; Bendroflumethiazide; Furosemide; Aripiprazole
Possible Clozapine side effects in male
Reported by a pharmacist from United States on 2012-06-12
Patient: male
Reactions: White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Possible Clozapine side effects in male
Reported by a pharmacist from United States on 2012-06-07
Patient: male
Reactions: White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clozapine
Page 1 Next >>
|
